Erratum to: Hepatocellular carcinoma: new options for image-guided ablation (Journal of Biliary-Pancreatic Sciences (DOI: 10.1007/s00534-009-0233-0);Hepatocellular carcinoma: New options for image-guided ablation

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 4, 2010, Pages 399-403

  Lencioni, Riccardo ^a   Cioni, Dania ^a   Della Pina, Clotilde ^a   Crocetti, Laura ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Hepatocellular carcinoma; Percutaneous ethanol injection; Radiofrequency ablation

Indexed keywords

TALAPORFIN;

APOPTOSIS; ARTICLE; CANCER CONTROL; CELL HYPOXIA; HIGH TEMPERATURE PROCEDURES; HUMAN; IMAGE GUIDED PERCUTANOEUS ABLATION; IRREVERSIBLE ELECTROPORATION; LIGHT ACTIVATED DRUG THERAPY; LIVER CELL CARCINOMA; MICROWAVE THERAPY; NONHUMAN; PERCUTANEOUS ETHANOL INJECTION; RADIOFREQUENCY ABLATION; TUMOR ABLATION; TUMOR NECROSIS; TUMOR RECURRENCE; ANIMAL; CATHETER ABLATION; ECHOGRAPHY; LIVER TUMOR; METHODOLOGY; REVIEW;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; HUMANS; LIVER NEOPLASMS;

EID: 79952112493     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-010-0312-2     Document Type: Erratum

References (20)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Bruix J, Sherman M, Llovet JM, et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421-30. (Pubitemid 32844200)
3. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-36. (Pubitemid 43112690)
4. Llovet JM, Di Bisceglie AM, Bruix J, et al. Panel of Experts in HCC-Design Clinical Trials. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 2008;100:698-711.
5. Lencioni R, Bartolozzi C, Caramella D, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer. 1995;76:1737-46.
6. Khan KN, Yatsuhashi H, Yamasaki K, et al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol. 2000;32:269-78. (Pubitemid 30093906)
7. Lencioni R, Cioni D, Crocetti L, Bartolozzi C. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl. 2004;10:S91-7.
8. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961-7. (Pubitemid 40250844)
9. Lencioni R, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228:235-40. (Pubitemid 36736097)
10. Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm. Gastroenterology. 2004;127:1714-23.
11. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation versus ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005;129:122-30. (Pubitemid 41002049)
12. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut. 2005;54:1151-6.
13. Brunello F, Veltri A, Carucci P, et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol. 2008;43:727-35. (Pubitemid 351868714)
14. Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: metaanalysis of randomized controlled trials. Am J Gastroenterol. 2009;104:514-24.
15. Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology. 2009;49:453-9.
16. Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology. 2005;234: 954-60. (Pubitemid 40250843)
17. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;26: 441-51. (Pubitemid 36313433)
18. Ebara M, Okabe S, Kita K, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol. 2005;43:458-64. (Pubitemid 41111427)
19. Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology. 2002;223: 331-7. (Pubitemid 34454307)
20. http://www.clinicaltrials.gov. Accessed 31 July 2009.